PPT-NSCLC with high PD-L1 expression on tumor cells or tumor-in

Author : test | Published Date : 2017-05-07

Intervista a Federico Cappuzzo Background Programmed deathligand 1 PDL1 expression on tumor cells TC or tumorinfiltrating immune cells IC is associated with OS

Presentation Embed Code

Download Presentation

Download Presentation The PPT/PDF document "NSCLC with high PD-L1 expression on tumo..." is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.

NSCLC with high PD-L1 expression on tumor cells or tumor-in: Transcript

Intervista a Federico Cappuzzo Background Programmed deathligand 1 PDL1 expression on tumor cells TC or tumorinfiltrating immune cells IC is associated with OS PFS and ORR in pts with advanced NSCLC treated with atezolizumab antiPDL1 MPDL3280A Spigel et al Spira et al ASCO 2015 indicating that PDL1 expression on both TC and IC is important for antitumor immunity However these 2 distinct expression patterns suggest the existence of previously unidentified NSCLC subtypes with distinct immunologic profiles . Circulating Tumor Cells (CTC). Metastasis. : the spread of cancer from its primary site to other places in the body.. Metastatic disease is the most common cause of cancer-related death in patients with solid tumors.. By: . Weigang. . wang. , . sumanta. . goswami. , Erik . sahai. , . jeffrey. . b. . wyckoff. , Jeffrey E. . Segall. and John S. . Condeelis. Presented By: Lana . Awad. and Sebastian Lukjan. Motivation of research, why they did what they did…. Gandara. , MD. University of California, Davis . Comprehensive Cancer Center. Biomarker-driven Phase III Clinical Trials: . Practical . & . Design Considerations. Clinical trial . d. esigns that define the. Le Chevalier, . MD. The Role of Translational Research . in . NSCLC. Outline of Talk. The importance of translational research in improving treatment of NSCLC. Key remaining unmet needs. Overview of promising approaches/agents in the future treatment of NSCLC . Nathan Pennell, M.D., Ph.D.. September 6, 2014. Objectives. Discuss the role of chemotherapy in molecularly defined populations. Discuss the addition of chemo and/or bevacizumab (Avastin) to targeted therapy. MD. The Evolving Treatment Landscape in NSCLC: Congress Updates. Outline of Talk. Provide a brief overview of current advances in the treatment of NSCLC. EGFR-targeted agents . ALK-EML4 targeted agents . of the expression of . 17-beta-hydroxysteroid . dehydrogenases. . type 1 and type 2 . in non-small cell lung cancer. Paweł Jagodziński. Hanna . Drzewiecka. ; M.Sc.. Ph. . D. student. Department of . By: . Weigang. . wang. , . sumanta. . goswami. , Erik . sahai. , . jeffrey. . b. . wyckoff. , Jeffrey E. . Segall. and John S. . Condeelis. Presented By: Lana . Awad. and Sebastian Lukjan. Motivation of research, why they did what they did…. Low TPS High TPS TPS = PD-L1 tumor proportion score Low TPS = 10%; high TPS = 60% No targetable mutation Low TPS High TPS EGFR mutation ALK rearrangement ROS1 rearrangement Low TPS High TPS BRAF V600E mutation Beth . Eaby. -Sandy, MSN, CRNP, OCN. ®. Nurse Practitioner. Abramson . Cancer Center of the University of Pennsylvania. Disclosure of Conflicts of Interest. Beth . Eaby. -Sandy, MSN, CRNP, . O. CN. ®. membersRatio of T/A 14a072641178c138779620c107786547c 193555999b149847581c011912833c025124807c035499832c074911907 mRNA 015479341015208943TIPE2 mRNA 017216480031272894TIEP3Proteinc112504259c121960550c1 Addressing Practical Clinical Questions Across the Metastatic Lung Cancer Continuum. Friday, October 11, 2019. 6:15 PM – 7:45 PM . Chicago, Illinois. Faculty. . Moderator. Joel W Neal, MD, PhD. Nasser H Hanna, MD. Professor Rachel Butler. The genomic complexity of advanced NSCLC. Jordan et al. Cancer Discovery (2017). >50% NSCLC now have actionable variant. Treatment algorithm. NHSE: National Genomic Test Directory. Adeetya's Kitchen & Furniture in Pune offers a selection of top-quality kitchen trolleys to maximize storage space and improve the functionality of any kitchen. https://adeetyas.com/high-quality-kitchen-trolleys-in-pune.php

Download Document

Here is the link to download the presentation.
"NSCLC with high PD-L1 expression on tumor cells or tumor-in"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.